abstract |
BACKGROUND OF THE INVENTION The present invention relates to the use of endothelin ET-A receptor antagonists for the treatment of bone metastases and metastatic growth, for the prevention of bone loss in cancer patients, for the alleviation of pain associated with cancer, for the prevention of metastases and for bone remodeling. SHE |